Sort
141,003 grants matching “cytokine”
Multispecific targeting incorporating cytokine receptor pathways in high risk pediatric acute leukemias to improve durability of adoptive cell therapy-induced remissions
$3,950,741Terry J. Fry · University Of Colorado Denver · U01 · FY2018 · CA
Genetic, Cellular and Molecular Mechanisms in Autoimmunity to Retina
$3,938,244Rachel R. Caspi · National Eye Institute · ZIA · FY2022 · EY
Lung Transplant Clinical Trial Network (LT-CTN)
$3,897,643Scott M Palmer · Duke University · U01 · FY2025 · AI
Human Biochemical Genetics
$3,897,217William Gahl · National Human Genome Research Institute · ZIA · FY2009 · HG
Pediatric Acute Liver Failure Immune Response Network (PALF IRN): Treatment for Immune Mediated Pathophysiology (TRIUMPH)
$3,894,611Estella M Alonso · Lurie Children'S Hospital Of Chicago · U01 · FY2022 · DK
Targeting Succinate Signaling for Innovative Pain Relief in Oral Cancer.
$3,892,146Xin Li · University Of Virginia · R01 · FY2025 · DE
IND-enabling Studies in Support of First in Human Safety Studies of a Novel Anti-Nicotine Human Monoclonal Antibody
$3,883,739Matthew W Kalnik · Antidote Therapeutics, Inc. · U01 · FY2025 · DA
Impact of MHC Genotype on Ex Vivo T cell Function in Type 1 Diabetes
$3,876,825Kai W Wucherpfennig · Dana-Farber Cancer Inst · DP3 · FY2012 · DK
Influenza responses and repertoire in vaccination, infection and tonsil organoids.
$3,874,619Mark M Davis · Stanford University · U19 · FY2020 · AI
Immune Pathophysiology of Aplastic Anemia and Immunosuppressive Treatments
$3,874,525Neal S Young · National Heart, Lung, And Blood Institute · ZIA · FY2017 · HL
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS
$3,863,029Jay A Berzofsky · Division Of Clinical Sciences - Nci · ZIA · FY2010 · CA
Project 3: Peribunyaviridae Pathogenesis and Vaccine Testing
$3,842,980Shannon Ronca · University Of California-Irvine · U19 · FY2024 · AI
GENERAL CLINICAL RESEARCH CENTER
$3,839,211New York University School Of Medicine · M01 · FY2001 · RR
Strategies for Cancer Immunotherapy Development: Preclinical Studies
$3,837,391Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
LcrV Plague Vaccine with Altered Immune Modulatory Properties
$3,835,703Olaf Schneewind · University Of Chicago · U01 · FY2008 · AI
Immune Pathophysiology of Aplastic Anemia and Immunosuppressive Treatments
$3,826,605Neal S Young · National Heart, Lung, And Blood Institute · ZIA · FY2018 · HL
Human Biochemical Genetics
$3,821,387William Gahl · National Human Genome Research Institute · ZIA · FY2011 · HG
Immune Pathophysiology of Aplastic Anemia and Immunosuppressive Treatments
$3,820,462Neal S Young · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL
NATIENS: A Phase III Randomized Double Blinded Study to Determine the Mechanisms and Optimal Management of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
$3,818,815Elizabeth Phillips · Vanderbilt University Medical Center · U01 · FY2020 · AI
B Cell Biology
$3,817,146Susan Pierce · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Calcium Signaling in Health and Disease
$3,816,281Anant Parekh · National Institute Of Environmental Health Sciences · ZIA · FY2025 · ES
The Neuroimmune System in Alzheimer's Disease
$3,811,561Joseph El-Khoury · Massachusetts General Hospital · RF1 · FY2015 · AG
Cytokine immunotherapies for melanoma
$3,810,235Marcus W Bosenberg · Yale University · U01 · FY2019 · CA
MPN Research Consortium
$3,805,296Ronald Hoffman · Icahn School Of Medicine At Mount Sinai · P01 · FY2020 · CA
Sleep Disruption and Alzheimer's Disease Pathology
$3,802,816Mark R Opp · University Of Colorado · RF1 · FY2019 · AG